Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma

PRŮKOVÁ, D., ANDĚRA, Ladislav, NAHÁCKA, Zuzana, KAROLOVÁ, J., SVATON, M., KLÁNOVÁ, M., HAVRÁNEK, O., SOUKUP, J., SVOBODOVÁ, K., ZEMANOVÁ, Z., TUŠKOVÁ, D., POKORNÁ, E., HELMAN, K., FORSTEROVA, K., PACHECO-BLANCO, M., VOČKOVÁ, P., BERKOVÁ, A., FROŇKOVÁ, E., TRNĚNÝ, M., KLENER, P. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 2019, 25(14), 4455-4465. ISSN 1078-0432. E-ISSN 1557-3265. Available: doi: 10.1158/1078-0432.CCR-18-3275.